跳至主要内容
临床试验/NCT01089218
NCT01089218已完成4 期

The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines

Seoul National University Hospital0 个研究点目标入组 241 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
241
主要终点
The incidence of fever

研究概览

简要总结

Fever can develop after fiberoptic bronchoscopy (FB) in about 2.5 - 16 % of adult patients. We evaluated the impact of oral amoxicillin/clavulanate (AC) on incidence of postbronchoscopic fever and pneumonia.

详细描述

For the population being undergone with bronchoscopy, the clinical signs and procedural measures for complication of bronchoscopy and cytokines will be checked.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients (aged 18 years or older) who underwent FB

排除标准

  • concurrent treatment with antibiotics or systemic corticosteroid

研究组 & 干预措施

control

No Intervention

control without intervention

干预措施: control (Drug)

Amoxicillin/clavulanate

Active Comparator

干预措施: oral amoxicillin/clavulanate 1g (875/125mg) (Drug)

结局指标

主要结局

The incidence of fever

时间窗: 24 hr after bronchoscopy

time frame for body temperature 24hr before and after bronchoscopy every 4hrs

次要结局

  • change of serum cytokines level(before bronchoscopy and 24hr after bronchoscopy)

研究者

申办方类型
Other

相似试验

The Impact of Antibiotic Prophylaxis on Incidence of... | 临床试验